All Industries

Top Drug Discovery Companies

241 Drug Discovery companies, sorted by total funding raised.

Hydra Biosciences, Inc.Closed

Private biopharmaceuticals company pioneering the discovery of novel drugs using its expertise in...

Cambridge, United States11–50Biotech, Drug Discovery
Series E·$72.2M·Mar 2015
Vilya

Computational biotechnology company designing de novo macrocycles with AI for therapeutic drug di...

Seattle, United States11–50Artificial Intelligence, Biotech
Series A·$71.0M·Jun 2024
Credence

Award-winning innovator in injectable drug delivery devices for pharmaceutical and biotechnology ...

Menlo Park, United States11–50Healthcare, Drug Discovery
Series D·$67.6M·Dec 2024
Surge Therapeutics

Develops an injectable intraoperative immunotherapy hydrogel to prevent post-surgical cancer recu...

Cambridge, United States1–10Biotech, Drug Discovery
Series B·$58.0M·Jul 2023
BiomX

Clinical‑stage company developing natural and engineered bacteriophage cocktails and personalized...

Ness Ziona, Israel51–200Biotech, Drug Discovery
Series B·$56.0M·Feb 2019
Jacobio PharmaIPO

China-based oncology drug discovery company developing induced allosteric inhibitors targeting th...

Beijing, China51–200Oncology, Drug Discovery
Series C·$55.0M·Aug 2018
Appia BioClosed

Develops allogeneic CAR‑iNKT cell therapies from hematopoietic stem cells to treat cancers, partn...

Los Angeles, United States11–50Biotech, Drug Discovery
Series A·$52.0M·May 2021
Rubedo Life Sciences

Clinical-stage biopharma developing therapies that target senescent/pathologic cells to treat age...

Sunnyvale, United States11–50Biotech, Drug Discovery
Series A·$52.0M·Apr 2024
Manas AI

AI-native biopharmaceutical company using neuro-symbolic models to accelerate drug discovery for ...

New York, United States1–10Life Sciences, Artificial Intelligence
Extension Round·$50.6M·Sep 2025
Magnet Biomedicine

Cambridge-based biotech using modular TrueGlue technology to discover molecular glues for the tre...

Cambridge, United StatesBiotech, Drug Discovery
Series A·$50.0M·Sep 2023
Virobay

Antiviral drug discovery and development company focused on treatments for autoimmune diseases, n...

Menlo Park, United States1–10Biotech, Drug Discovery
Series B·$48.0M·Jul 2014
Ribometrix

RNA structure therapeutics

Durham, United States11–50Biotech, Drug Discovery
Venture Round·$45.3M·Sep 2019
Peptone

Biotechnology company designing small-molecule therapeutics that target intrinsically disordered ...

London, United Kingdom11–50Artificial Intelligence, Biotech
Series A·$42.5M·Jun 2022
Arpeggio Bio

Arpeggio Bio develops drugs targeting transcription factors using AI…

Boulder, United States11–50Biotech, Drug Discovery
Series B·$40.2M·Nov 2025
Creyon

AI-driven drug development company creating tissue-specific RNA-targeted oligonucleotide medicines.

United StatesArtificial Intelligence, Biotech
Series A·$40.0M·Mar 2022
MB
Mantra Bio

Biotechnology company developing targeted exosome-based therapeutics using its proprietary REVEAL...

United StatesBiotech, Drug Discovery
Series A·$39.0M·Jan 2023
Valinor Discovery

Frontier ML lab training virtual patient foundation models on multi-omic and clinical datasets to...

Salt Lake City, United States1–10Artificial Intelligence, Biotech
Venture Round·$38.0M·Feb 2026
Anagenex

Drug discovery company combining DNA-encoded library technology with machine learning to identify...

Artificial Intelligence, Biotech
Series A·$37.2M·Jun 2022
Shiru

Shiru leverages ML to create proteins to feed the world sustainably.

Emeryville, United States1–10Agtech, Artificial Intelligence
Series B·$36.6M·Nov 2024
ReceptosClosed

Biopharmaceutical company that developed immune-inflammatory therapies, notably ozanimod (RPC-106...

San Diego, United States51–200Biotech, Drug Discovery
Venture Round·$35.8M·Mar 2012
Permanence Bio

Developing therapeutics to stop mutations to prevent cancer

San Francisco, United States1–10Biotech, Drug Discovery
Series A·$35.0M·Jan 2026
Transcode Therapeutics, Inc.

R&D company with 3 SBIR/STTR awards from Department of Health and Human Services.

Boston, United States1–10Biotech, Drug Discovery
Series B·$33.0M·Oct 2025
Aspen RxHealth

Digital health platform connecting health plans with on-demand pharmacist community for medicatio...

United StatesDigital Health, Drug Discovery
Series B·$32.0M·Jan 2021
Reverie LabsClosed

Engineering next-generation, brain-penetrant cancer therapies.

Cambridge, United States11–50Biotech, Drug Discovery
Series A·$32.0M
Sorriso Pharmaceuticals

Sorriso Pharmaceuticals is a biotechnology company advancing a pipeline of disease-modifying anti...

Sandy, United States1–10Biotech, Drug Discovery
Series A·$31.0M·Dec 2021